FDA Adverse Event Injury Summary report: N

RENAL - DISPOSABLE

MDR report key: 1802183 · Received August 17, 2010

Report

Report Number
1423500-2010-02568
Event Type
Injury
Date Received
August 17, 2010
Date of Event
July 27, 2010
Report Date
August 12, 2010
Manufacturer
UNKNOWN MANUFACTURING FACILITY
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE PATIENTS DISCARD THE SAMPLES AFTER EACH THERAPY, THEREFORE NO SAMPLE WAS RETURNED FOR EVALUATION. THIS INTERNATIONAL PRODUCT IS DISTRIBUTED OUTSIDE THE U.S. AND DOES NOT HAVE A 510K NUMBER, BUT IT IS BEING REPORTED AS IT IS THE SAME OR SIMILAR TO A PRODUCT DISTRIBUTED WITHIN THE U.S.

Description of Event or Problem · 1

THIS IS A SPONTANEOUS REPORT BY A BAXTER EMPLOYED NURSE FROM (B)(4) OF PERITONITIS IN A (B)(6) MALE PATIENT COINCIDENT WITH DIANEAL PD2 ULTRABAG THERAPY. IN (B)(6) 2010, THE PATIENT STARTED TREATMENT WITH DIANEAL PD2 ULTRABAG INTRAPERITONEALLY (IP) FOR PERITONEAL DIALYSIS (PD). ON (B)(6) 2010, THE PATIENT WAS DIAGNOSED WITH PERITONITIS. THE CAUSE OF THE PERITONITIS WAS UNKNOWN. ON THE SAME DAY, A PERITONEAL EFFLUENT ANALYSIS AND CULTURE WERE PERFORMED. THE ANALYSIS REVEALED 920 CELLS/MM3 LEUKOCYTES WITH 60% NEUTROPHILS AND 40% LYMPHOCYTES. THE RESULTS OF THE CULTURE WERE UNKNOWN. ON (B)(6) 2010, THE PATIENT BEGAN REMEDIAL THERAPY WITH FORTUM (1GM, DAILY, IP) AND REFLIN (1GM, LOADING DOSE, IP). DIANEAL THERAPY WAS ONGOING AS WELL AS REMEDIAL THERAPY WITH FORTUM. IT WAS UNKNOWN WHETHER THE PERITONITIS RESOLVED. THE NURSE BELIEVED THAT THE PERITONITIS WAS NOT RELATED TO DIANEAL THERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RENAL - DISPOSABLE SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ UNKNOWN MANUFACTURING FACILITY UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 58 YR Required Intervention DIANEAL PD2 ULTRABAG THERAPY. IN (B)(6)2010, THE P